Background: Methotrexate is an antagonist of folic acid that has been shown to be genotoxic to healthy body cells via induction of oxidative stress. Cilostazol is a phosphodiesterase III inhibitor and a potent antioxidant drug.
Objective: To evaluate the potential protective effect of cilostazol on methotrexate genotoxicity.
Methods: The genotoxic effect of methotrexate by measuring the frequency of chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) in human cultured lymphocytes was studied.
Results: Methotrexate significantly increased the frequency of CAs and SCEs (p < 0.0001) as compared to control cultures. This chromosomal damage induced by methotrexate was considerably decreased by pretreatment of the cells with cilostazol (P < 0.01). Moreover, the results showed that methotrexate resulted in a notable reduction (P < 0.01) in cells kinetic parameters, the mitotic index (MI) and the proliferative index (PI). Similarly, cilostazol significantly reduced the mitotic index, which could be related to the anti-proliferative effect (P < 0.01).
Conclusion: Methotrexate is genotoxic, and cilostazol could prevent the methotrexate-induced chromosomal damage with no modulation of methotrexate-induced cytotoxicity.
[http://dx.doi.org/10.1177/1043454214563409] [PMID: 25637187]
[http://dx.doi.org/10.1002/emmm.200900040] [PMID: 20049736]
[http://dx.doi.org/10.3748/wjg.v20.i29.10158] [PMID: 25110444]
[http://dx.doi.org/10.1111/bph.12021] [PMID: 23072581]
[http://dx.doi.org/10.1002/jcp.28140] [PMID: 30667057]
[http://dx.doi.org/10.1073/pnas.93.12.5765] [PMID: 8650167]
[http://dx.doi.org/10.1007/s00204-006-0128-7] [PMID: 16826409]
[http://dx.doi.org/10.1016/j.mrfmmm.2006.05.030] [PMID: 16814813]
[http://dx.doi.org/10.1080/01480545.2016.1209678] [PMID: 27461518]
[http://dx.doi.org/10.1016/j.lfs.2012.07.003] [PMID: 22820172]